Salud financiera de hoja de balance de RepliCel Life Sciences
Salud financiera controles de criterios 0/6
RepliCel Life Sciences has a total shareholder equity of CA$-5.0M and total debt of CA$1.2M, which brings its debt-to-equity ratio to -25%. Its total assets and total liabilities are CA$172.7K and CA$5.2M respectively.
Información clave
-25.0%
Ratio deuda-patrimonio
CA$1.24m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | CA$148.95k |
| Patrimonio | -CA$4.98m |
| Total pasivo | CA$5.15m |
| Activos totales | CA$172.68k |
Actualizaciones recientes sobre salud financiera
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: REPC.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: REPC.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: REPC.F has negative shareholder equity, which is a more serious situation than a high debt level.
Reducción de la deuda: REPC.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cobertura de la deuda: REPC.F's operating cash flow is negative, therefore debt is not well covered.
Cobertura de intereses: Insufficient data to determine if REPC.F's interest payments on its debt are well covered by EBIT.